Ensaios Clínicos (somente visualização)

Listagem completa dos ensaios clĂ­nicos importados do XML ICTRP.

Back
4889
RBR-5d758t9
A Clinical Study for Safety and Immunogenicity Increment after Extra Dose with Chadox1-S/NCOV-19 or third dose of Coronavac in previously Vaccinated Elderly subjects
A Randomized, Patient-Single-Blind Phase IV Clinical Study for Assessing the Safety and Laboratory Immunogenicity Increment after Vaccine Booster with Chadox1-S/NCOV-19 or third dose of Coronavac in previously Vaccinated Elderly subjects
None
Not yet recruiting
Intervention
4, randomized-controlled, single-blind
4
None
None
None
2021-09-15
2021-09-18
None
None
Instituto do Câncer Brasil (unidade Ribeirão Preto)
Instituto do Câncer Brasil (unidade Ribeirão Preto)
https://ensaiosclinicos.gov.br/rg/RBR-5d758t9
None
Male or female participants; aged 60 years or older; previously vaccinated with CoronaVac; Have previously received 2 doses of CoronaVac, as per the national immunization plan; the second dose administered at least 30 days ago.
Have had Covid-19 after the start of the vaccination schedule with CoronaVac; Symptoms of infection of any organ or etiology in the last 30 days, as per investigator’s judgment; Have had contact with an individual diagnosed with COVID-19 in the work or home environment in the last 10 days;Subjects with AIDS, severe immunosuppression or patients with a severe disease, as per investigator’s judgment.Have a Karnofsky Performance status below or lower than 70 (Attachment A). Known allergy to the components of the vaccines used in the study. Participation in another clinical study in less than 1 year (unless participation is justifiable as per the principal investigator).
None
None
None
None
2026-05-11 05:20:45